The decreased levels of cytokine expression were correlated to the ratio of MSCs and PBMCs, indicating that in vitro secretion of IL-17 by PBMCs from highly activated RA patients was inhibited by MSCs in a dose-dependent manner. This evidence concerns the gene IL17A and rheumatoid arthritis.